| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/04/2011 | CA2360692C Noninvasive vaccination through the skin |
| 01/04/2011 | CA2350127C Avipox vector coding an hiv antigen and a cytokine |
| 01/04/2011 | CA2335645C Use of interferon alpha 5 in the treatment of viral liver diseases |
| 01/04/2011 | CA2319672C Compounds and compositions for delivering active agents |
| 01/04/2011 | CA2304988C Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 01/04/2011 | CA2285018C Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof |
| 01/04/2011 | CA2283754C Use of avian antibodies |
| 01/04/2011 | CA2268865C Anti-p53 single-chain antibody fragments and their uses |
| 01/04/2011 | CA2248869C Allele suppression |
| 01/04/2011 | CA2246747C Method of promoting bone growth with hyaluronic acid and growth factors |
| 01/04/2011 | CA2246744C Immunomodulatory complex and use thereof in diseases caused by helicobacter |
| 01/04/2011 | CA2231916C Erythrocytes loaded with s-nitrosothiol and uses therefor |
| 01/04/2011 | CA2163439C Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 01/04/2011 | CA2101774C Test and model for alzheimer's disease |
| 01/04/2011 | CA2068654C Varicella-zoster virus antigen |
| 12/30/2010 | US20100333221 Mutated hyperthermophilic phosphotriesterases and uses thereof |
| 12/30/2010 | US20100333218 Transgenic proteins from multi-gene systems, methods, compositions, uses and the like relating thereto |
| 12/30/2010 | US20100333216 Non-human gene-disrupted animal with disrupted Adam11 gene |
| 12/30/2010 | US20100331970 Compounds and Methods for the Prevention or Treatment of Restenosis |
| 12/30/2010 | US20100331815 Transluminal delivery of oncoltyic viruses for cancer therapy |
| 12/30/2010 | US20100331611 Embryo implantation |
| 12/30/2010 | US20100331537 Novel surface antigen |
| 12/30/2010 | US20100331536 CA125 gene and its use for diagnostic and therapeutic interventions |
| 12/30/2010 | US20100331535 Conjugates and compositions for cellular delivery |
| 12/30/2010 | US20100331529 Methods for increasing protein polyethylene glycol (peg) conjugation |
| 12/30/2010 | US20100331528 Isolated Antibodies Against Biologically Active Leptin-Related Peptides |
| 12/30/2010 | US20100331489 Branched water-soluble polymers and their conjugates |
| 12/30/2010 | US20100331395 Decoy-containing pharmaceutical compositions and method of using the same |
| 12/30/2010 | US20100331390 Effects of apolipoprotein b inhibition on gene expression profiles in animals |
| 12/30/2010 | US20100331355 Substituted Quinolines for the Treatment of Cancer |
| 12/30/2010 | US20100331266 Analysis of amino acid copolymer compositions |
| 12/30/2010 | US20100331265 Methods for the prevention and treatment of burn injuries and secondary complications |
| 12/30/2010 | US20100331264 Preserving secondary peptide structure |
| 12/30/2010 | US20100331263 Methods and compositions for inhibiting angiogenesis |
| 12/30/2010 | US20100331262 PEPTIDE VACCINE USING MIMIC MOLECULES OF AMYLOID Beta PEPTIDE |
| 12/30/2010 | US20100331261 Use of alpha-1-antitrypsin for the preparation of drugs for the treatment of chronic fatigue syndrome |
| 12/30/2010 | US20100331259 Use of a neurotoxic component of a clostridium botulinum toxin complex to reduce or prevent side effects. |
| 12/30/2010 | US20100331258 memory in subjects with mini-mental state examination of 24-26 |
| 12/30/2010 | US20100331257 Preparation of terminally-sterilized collagen that is soluble at neutral ph |
| 12/30/2010 | US20100331256 Variants of C-Type Natriuretic Peptides |
| 12/30/2010 | US20100331255 Compositions and Methods for Increasing Production of Recombinant Gamma-Carboxylated Proteins |
| 12/30/2010 | US20100331254 Pulverized fibrin clots and pharmaceutical compositions containing them |
| 12/30/2010 | US20100331253 Method for cell adhesion and wound healing |
| 12/30/2010 | US20100331252 Myostatin inhibitor enhancement of musculoskeletal repair |
| 12/30/2010 | US20100331251 Polypeptides homologous to vegf and bmp1 |
| 12/30/2010 | US20100331250 Anti-angiogenesis fusion proteins |
| 12/30/2010 | US20100331249 Pharmaceutical composition for inhibiting peritoneal dissemination |
| 12/30/2010 | US20100331248 Compositions and methods for treating diabetes using lisofylline and islet neogenesis associated peptide |
| 12/30/2010 | US20100331247 Peptide therapy for hyperglycemia |
| 12/30/2010 | US20100331246 Ester-based insulin prodrugs |
| 12/30/2010 | US20100331245 Peptide yy analogs |
| 12/30/2010 | US20100331244 Pharmaceutical composition, food or drink, and methods related thereto |
| 12/30/2010 | US20100331243 Organic compounds and their uses |
| 12/30/2010 | US20100331242 Method of using lectins for prevention and treatment of oral and alimentary tract disorders |
| 12/30/2010 | US20100331241 Bacteriocins and Novel Bacterial Strains |
| 12/30/2010 | US20100331240 Methods for prevention and treatment of infections with supraphysiological doses of mannan-binding lectin (mbl) and ficolin-mbl fusion proteins |
| 12/30/2010 | US20100331239 Cd14 and peptides thereof for protection of cells against cell death |
| 12/30/2010 | US20100331238 Human G protein-coupled receptor and modulators thereof for the treatment of atherosclerosis and atherosclerotic disease and for the treatment of conditions related to MCP-1 expression |
| 12/30/2010 | US20100331237 Gag binding proteins |
| 12/30/2010 | US20100331236 Cyclic peptides as g-protein coupled receptor antagonists |
| 12/30/2010 | US20100331235 Histidine and/or Histidine Derivative for the Treatment of Inflammatory Skin Diseases |
| 12/30/2010 | US20100331234 Aminoalcohol lipidoids and uses thereof |
| 12/30/2010 | US20100331233 Crystal of xpa and ercc1 complex and uses thereof |
| 12/30/2010 | US20100331232 Starch-based hydrogel for biomedical applications |
| 12/30/2010 | US20100330673 Methods of making enhanced, autologous fat grafts |
| 12/30/2010 | US20100330669 Fvii or fviia variants |
| 12/30/2010 | US20100330668 Interaction Between the VHL Tumour Suppressor and Hypoxia Inducible Factor, and Assay Methods Relating Thereto |
| 12/30/2010 | US20100330657 Activin receptor-like kinases, proteins having serine threonine kinase domains and their use |
| 12/30/2010 | US20100330201 Therapeutic methods and pharmaceutical compositions for treating warts with tellurium compounds |
| 12/30/2010 | US20100330199 Isothiazole-pyridine derivates as modulators of hif (hypoxia inducible factor) activity |
| 12/30/2010 | US20100330191 Diaminooxidase-containing pharmaceutical compositions |
| 12/30/2010 | US20100330184 Injection vehicle for polymer-based formulations |
| 12/30/2010 | US20100330182 Tendon Stem Cells |
| 12/30/2010 | US20100330173 Compounds and methods for treating influenza |
| 12/30/2010 | US20100330163 Compositions and Methods for Enhancing Metal Ion Dependent Drug Therapies |
| 12/30/2010 | US20100330159 System for transporting active substances in a biological system |
| 12/30/2010 | US20100330158 Protein-assisted drug delivery system for the targeted administration of active agents |
| 12/30/2010 | US20100330157 Biomaterial for the controlled delivery of ingredients |
| 12/30/2010 | US20100330155 METHODS AND COMPOSITIONS FOR IMPROVED THERAPEUTIC EFFECTS WITH siRNA |
| 12/30/2010 | US20100330154 amphoteric liposomes comprising neutral lipids |
| 12/30/2010 | US20100330152 Methods and compositons for antisense vegf oligonucleotides |
| 12/30/2010 | US20100330148 Mehods and compositions for inhibiting impdh-1 isoform 1 |
| 12/30/2010 | US20100330145 Biobeneficial coating compositions and methods of making and using thereof |
| 12/30/2010 | US20100330143 Modified macromolecules and methods of making and using thereof |
| 12/30/2010 | US20100330115 Multivariable Antigens Complexed with Targeting Humanized Monoclonal Antibody |
| 12/30/2010 | US20100330109 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 12/30/2010 | US20100330104 Methods of using btl-ii proteins |
| 12/30/2010 | US20100330097 Predicting amd with snps within or near c2, factor b, plekha1, htra1, prelp, or loc387715 |
| 12/30/2010 | US20100330096 Methods of treating diseases with anti-vegf antibodies |
| 12/30/2010 | US20100330085 Method of treatment, prophylaxis and diagnosis of pathologies of the bone |
| 12/30/2010 | US20100330083 Plasminogen activator variant formulations |
| 12/30/2010 | US20100330079 Biomarkder combinations for colorectal cancer |
| 12/30/2010 | US20100330073 Methods of treatment using antibodies to neutrokine-alpha |
| 12/30/2010 | US20100330072 Myostatin binding agents |
| 12/30/2010 | US20100330070 Methods Of Making An Antibody And Compositions Thereof |
| 12/30/2010 | US20100330067 Compounds and Methods for the Modulation of Toll-Like Receptor Function |
| 12/30/2010 | US20100330065 Compositions and methods for treating collagen-mediated diseases |
| 12/30/2010 | US20100330064 2-mercaptocyclopentanecarboxylic acid compounds, a process for their preparation and pharmaceutical compositions containing them |
| 12/30/2010 | US20100330063 Stem-like cells, method for de-differentiating mammalian somatic cells into stem-like cells, and method for differentiating stem-like cells |
| 12/30/2010 | US20100330062 Klotho protein and related compounds for the treatment and diagnosis of cancer |